Questcor Pharmaceuticals, Inc.

1300 North Kellogg Drive Suite D,
Anaheim, California 92807
United States,
(714) 786-4200
www.questcor.com

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company that provides drugs for the treatment of autoimmune and inflammatory disorders.

M&A Summary

Buy vs Sell

Year ≤ '08 '09 '10 '11 '12 '13 T
Buy (0.4/yr) # 1 - - - - 2 3
vol $98M $98M
Sell (0.0/yr) # - - - - - - 0
  3

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Rights to Synacthen
$60M (2013-06-11)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Questcor Pharmaceuticals was acquired by Mallinckrodt on August 14, 2014.

Questcor Pharmaceuticals has acquired 3 companies of its own, including 2 in the last 5 years.

Questcor Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Rights to Synacthen for $60M. Questcor Pharmaceuticals has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 420 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Questcor Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.